The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $28,491.20 firm fixed price purchase order to New England Biolabs, Inc. for NEBNext® UltraTM II Directional RNA Library Prep Reagents. The place of performance is the prime contractor's facility in Ipswich, Massachusetts. The period of performance is from August 14, 2023 through September 29, 2023. The original solicitation sought NEBNext® UltraTM II Directional RNA...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $22,158.40 firm fixed price purchase order to New England Biolabs, Inc. (NEB) for the delivery of NEBNEXT MULTIPLEX OLIGOS FOR ILLUMINA (96 UNIQUE DUAL INDEX PRIMER PAIRS). This order is not set aside for any specific business type. NEB is a for-profit manufacturer of molecular biology reagents, kits, and enzymes that regularly supplies the NIH and other federal agencies...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order contract to New England Biolabs, Inc. (NEB) for the supply of NEB NEXT ULTRA II DIRECTIONAL RNA LIBRARY PREP. The $38,892.00 contract does not have a set-aside designation and is for delivery to NEB's headquarters in Ipswich, MA. NEB is a manufacturer and supplier of reagents, kits, and enzymes for the life sciences industry, and has...
This is a $124,492.25 firm fixed price purchase order awarded by the National Institutes of Health (NIH) to New England Biolabs, Inc. (NEB) for the procurement of NEBNEXT reagents. The contract has no set-aside designation. NEB is a manufacturer and supplier of reagents, kits, and enzymes for the life sciences industry, and has previously provided goods such as RNA-seq kits, reagent kits, and COVID-19 research supplies to federal agencies including NIH, CDC, NOAA, FBI, and NIAID. In addition...
This federal contract award to New England Biolabs, Inc. (NEB) was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $26,754.00 Firm Fixed Price purchase order is for the supply of the NEBNext mRNA Second Strand Synthesis Module, a 100-reaction kit used in RNA library preparation for next-generation sequencing applications. The contract does not have a set-aside designation. NEB, a leading manufacturer and...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to New England Biolabs, Inc. (NEB), a manufacturer of reagents, kits, and enzymes for the life sciences industry. The $158,884.80 contract is for the delivery of enzymatic kits for sequencing, with a completion date of February 28, 2025. The contract has no set-aside designation. NEB has previously received federal awards from agencies such as...
This firm fixed-price purchase order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to New England Biolabs, Inc. (NEB) for the supply of NEBNext Multiplex Oligos for Illumina (96 unique dual index primer pairs) (384). The contract has a ceiling value of $24,304.00 and a completion date of October 5, 2024. NEB is a leading manufacturer of molecular biology products, including reagents, kits, and enzymes, that support...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order to New England Biolabs, Inc. (NEB) for the delivery of enzyme kits. The potential value of the contract is $100,464.00 and the completion date is September 25, 2020. NEB is a manufacturer and supplier of reagents, kits, and enzymes for the life sciences industry. Through prior federal contract awards and subcontractor roles, NEB has provided various...
This purchase order award from the Department of Health and Human Services' National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases to New England Biolabs, Inc. is for $17,224.80 worth of RNA-seq kits. The place of performance is in Ipswich, Massachusetts and the contract completion date is January 20, 2025. As a manufacturer of goods, New England Biolabs will deliver the requested biological kits with no set-aside designation involved. The RNA-seq...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $10,508 purchase order to New England Biolabs, Inc., doing business as New England Biolabs, for reagent kits under catalog number 2186318. The firm fixed price order is for the delivery of these products to the prime contractor's facility in Ipswich, Massachusetts, with performance spanning from September 25, 2023 to December 1, 2023. No subcontractors or set...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,032 firm fixed price purchase order to New England Biolabs, Inc. for NEBNEXT ULTRA II Q5 MASTER MIX. The master mix reagent is needed to support amplification of DNA for next generation sequencing in a high-throughput chromatin assay. The sources sought notice specified a need for 40 units of the 500 reaction size product to support research activities at the National Center for Advancing Translational Sciences, which aims to catalyze innovation in translational science methods and technologies. Place of performance is Ipswich, Massachusetts and the period of performance is August 7-25, 2023.